Answers are grounded in this paper and cite their sources.
Background/Objectives To investigate the long-term efficacy and safety of adalimumab(ADA) in the treatment of patients with serpiginous choroiditis (SC) refractory to conventional therapy through quantitative parameters.
No takes yet. Share an insight, caveat, or question.
Özkoçak et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: